Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

SPONSORED – Neuropathy affects ... problem without getting to the root cause. Health From Within Chiropractic has a better solution that does not involve drugs or surgery. Hear more about ...

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...

The drug was well-tolerated, and the trial results suggested potential for rapid improvement in peripheral neuropathy symptoms and long-lasting effects compared to a placebo. Akhilesh Sharma ...

In March 2023, my 94-year-old mother had a shingles episode on the right side of her neck, head, ear and (to a lesser degree) right cheek. The ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

manufacture and commercialise the drug in India. India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a major one. Diabetic ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at the Pain Therapeutics Summit in BostonMIAMI, FL ...

Investigational New Drug (IND) application for its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...